Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | AMENDMENT NO 1 TO REGISTRATION STATEMENT | fs42022a1_larkspurhealth.htm iXBRL | S-4/A | 15230053 |
2 | FORM OF CERTIFICATE OF DESIGNATION OF LARKSPUR HEALTH ACQUISITION CORP. RELATING | fs42022a1ex3-3_larkspur.htm | EX-3.3 | 159828 |
3 | FORM OF WARRANT ISSUED BY THE REGISTRANT TO EACH PRIVATE PLACEMENT INVESTOR | fs42022a1ex4-2_larkspur.htm | EX-4.2 | 114858 |
4 | FORM OF WARRANT PURSUANT TO LICENSE AGREEMENT, DATED APRIL 18, 2019, BY AND BETW | fs42022a1ex4-3_larkspur.htm | EX-4.3 | 125014 |
5 | FORM OF WARRANT PURSUANT TO LICENSE AGREEMENT, DATED DECEMBER 15, 2015, BY AND B | fs42022a1ex4-4_larkspur.htm | EX-4.4 | 82670 |
6 | OPINION OF ALSTON & BIRD LLP AS TO THE VALIDITY OF THE SHARES OF COMMON STOCK AN | fs42022a1ex5-1_larkspur.htm | EX-5.1 | 17630 |
7 | FORM OF INCENTIVE STOCK OPTION AWARD AGREEMENT UNDER THE COMBINED ENTITY 2022 OM | fs42022a1ex10-6i_larkspur.htm | EX-10.6(1) | 42007 |
8 | FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE COMBINED ENTITY 2022 OMN | fs42022a1ex10-6ii_larkspur.htm | EX-10.6(2) | 26400 |
9 | FORM OF NON-QUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE COMBINED ENTITY 202 | fs42022a1ex10-6iii_larkspur.htm | EX-10.6(3) | 38625 |
10 | VARIANT PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN | fs42022a1ex10-7_larkspur.htm | EX-10.7 | 100811 |
11 | LICENSE AGREEMENT, DATED APRIL 18, 2019, BY AND BETWEEN INFLAMACORE, LLC AND VAR | fs42022a1ex10-14_larkspur.htm | EX-10.14 | 300551 |
12 | LICENSE AGREEMENT, DATED DECEMBER 15, 2015, BY AND BETWEEN L&F RESEARCH LLC AND | fs42022a1ex10-15_larkspur.htm | EX-10.15 | 260340 |
13 | FIRST AMENDMENT TO LICENSE AGREEMENT, DATED JANUARY 9, 2020, BY AND BETWEEN L&F | fs42022a1ex10-16_larkspur.htm | EX-10.16 | 16834 |
14 | FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF [ ], 2022, BY AND AMONG LARKS | fs42022a1ex10-17_larkspur.htm | EX-10.17 | 276305 |
15 | FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, BY AND AMONG LARKSPU | fs42022a1ex10-18_larkspur.htm | EX-10.18 | 167380 |
16 | FORM OF AMENDMENT #1 TO THE SECURITIES PURCHASE AGREEMENT, DATED AS OF [__], 202 | fs42022a1ex10-19_larkspur.htm | EX-10.19 | 22111 |
17 | EXECUTIVE EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 13, 2022, BY AND BETWEEN S | fs42022a1ex10-20_larkspur.htm | EX-10.20 | 170002 |
18 | EXECUTIVE EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 13, 2022, BY AND BETWEEN N | fs42022a1ex10-21_larkspur.htm | EX-10.21 | 142241 |
19 | EXECUTIVE EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 13, 2022, BY AND BETWEEN K | fs42022a1ex10-22_larkspur.htm | EX-10.22 | 147955 |
20 | EXECUTIVE EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 13, 2022, BY AND BETWEEN P | fs42022a1ex10-23_larkspur.htm | EX-10.23 | 137750 |
21 | CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF LARKSPUR | fs42022a1ex23-1_larkspur.htm | EX-23.1 | 2672 |
22 | CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF Z | fs42022a1ex23-2_larkspur.htm | EX-23.2 | 2004 |
23 | CONSENT OF STEPHEN C. GLOVER TO BE NAMED AS A DIRECTOR | fs42022a1ex99-2_larkspur.htm | EX-99.2 | 2980 |
24 | CONSENT OF ROBERT G. FINIZIO TO BE NAMED AS A DIRECTOR | fs42022a1ex99-3_larkspur.htm | EX-99.3 | 2980 |
25 | CONSENT OF MIN-CHUL PARK, PH.D. TO BE NAMED AS A DIRECTOR | fs42022a1ex99-4_larkspur.htm | EX-99.4 | 3063 |
26 | CONSENT OF DANIEL J. O'CONNOR TO BE NAMED AS A DIRECTOR | fs42022a1ex99-5_larkspur.htm | EX-99.5 | 3001 |
27 | CONSENT OF CASSEL SALPETER & CO., LLC | fs42022a1ex99-6_larkspur.htm | EX-99.6 | 3916 |
28 | FILING FEE TABLE | fs42022a1ex-fee_larkspur.htm | EX-FILING FEES | 13688 |
29 | GRAPHIC | timage_001.jpg | GRAPHIC | 76117 |
30 | GRAPHIC | timage_002.jpg | GRAPHIC | 591467 |
31 | GRAPHIC | timage_003.jpg | GRAPHIC | 666305 |
32 | GRAPHIC | timage_004.jpg | GRAPHIC | 324455 |
33 | GRAPHIC | timage_005.jpg | GRAPHIC | 197067 |
34 | GRAPHIC | timage_006.jpg | GRAPHIC | 670994 |
35 | GRAPHIC | tbarchart_001.jpg | GRAPHIC | 284836 |
36 | GRAPHIC | timage_007.jpg | GRAPHIC | 556581 |
37 | GRAPHIC | timage_008.jpg | GRAPHIC | 246644 |
38 | GRAPHIC | timage_009.jpg | GRAPHIC | 671161 |
39 | GRAPHIC | timage_010.jpg | GRAPHIC | 630408 |
40 | GRAPHIC | timage_011.jpg | GRAPHIC | 698602 |
41 | GRAPHIC | timage_012.jpg | GRAPHIC | 440370 |
42 | GRAPHIC | timage_013.jpg | GRAPHIC | 459052 |
43 | GRAPHIC | timage_014.jpg | GRAPHIC | 303134 |
44 | GRAPHIC | timage_015.jpg | GRAPHIC | 430309 |
45 | GRAPHIC | timage_016.jpg | GRAPHIC | 232315 |
46 | GRAPHIC | timage_017.jpg | GRAPHIC | 393093 |
47 | GRAPHIC | timage_018.jpg | GRAPHIC | 478719 |
48 | GRAPHIC | timage_019.jpg | GRAPHIC | 679633 |
49 | GRAPHIC | timage_020.jpg | GRAPHIC | 452220 |
50 | GRAPHIC | tbarchart_002.jpg | GRAPHIC | 326417 |
51 | GRAPHIC | tlinechart_001.jpg | GRAPHIC | 298205 |
52 | GRAPHIC | timage_021.jpg | GRAPHIC | 1175670 |
53 | GRAPHIC | timage_022.jpg | GRAPHIC | 435621 |
54 | GRAPHIC | tcassel_logo.jpg | GRAPHIC | 53432 |
55 | GRAPHIC | tcasselfooter.jpg | GRAPHIC | 80491 |
56 | GRAPHIC | ex5-1_001.jpg | GRAPHIC | 7211 |
Complete submission text file | 0001213900-22-059148.txt | 53179835 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
57 | XBRL SCHEMA FILE | lhac-20220630.xsd | EX-101.SCH | 49930 |
58 | XBRL CALCULATION FILE | lhac-20220630_cal.xml | EX-101.CAL | 19433 |
59 | XBRL DEFINITION FILE | lhac-20220630_def.xml | EX-101.DEF | 183356 |
60 | XBRL LABEL FILE | lhac-20220630_lab.xml | EX-101.LAB | 333275 |
61 | XBRL PRESENTATION FILE | lhac-20220630_pre.xml | EX-101.PRE | 189642 |
99 | EXTRACTED XBRL INSTANCE DOCUMENT | fs42022a1_larkspurhealth_htm.xml | XML | 961371 |
IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-266838 | Film No.: 221267490
SIC: 2834 Pharmaceutical Preparations